{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:21:00Z","timestamp":1790263260794,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.vaccine.2011.04.059","type":"journal-article","created":{"date-parts":[[2011,12,18]],"date-time":"2011-12-18T20:50:32Z","timestamp":1324241432000},"page":"D91-D96","source":"Crossref","is-referenced-by-count":59,"special_numbering":"S4","title":["Measles and rubella eradication in the Americas"],"prefix":"10.1016","volume":"29","author":[{"given":"Jon Kim","family":"Andrus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro A.","family":"de Quadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Castillo Sol\u00f3rzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirta","family":"Roses Periago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"SU01","key":"10.1016\/j.vaccine.2011.04.059_bib0005","first-page":"23","article-title":"The principles of disease elimination and eradication","volume":"48","author":"CDC","year":"1999","journal-title":"MMWR"},{"issue":"2","key":"10.1016\/j.vaccine.2011.04.059_bib0010","first-page":"91","article-title":"Accelerating, policy, deployment, and access to new and underutilized vaccines in developing countries","volume":"7","author":"Andrus","year":"2006","journal-title":"Harvard Health Policy Rev"},{"issue":"89","key":"10.1016\/j.vaccine.2011.04.059_bib0015","first-page":"349","article-title":"Measles vaccines: WHO position paper","volume":"35","author":"WHO","year":"2009","journal-title":"WER"},{"issue":"3","key":"10.1016\/j.vaccine.2011.04.059_bib0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1586\/14760584.7.3.355","article-title":"Feasibility of global measles eradication after interruption of transmission in the Americas","volume":"7","author":"de Quadros","year":"2008","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2011.04.059_bib0025","unstructured":"Andrus JK, de Quadros CA, Castillo-Solorzano C. Chapter 54: measles in tropical infectious diseases, 3rd ed.; in press."},{"key":"10.1016\/j.vaccine.2011.04.059_bib0030","first-page":"84","article-title":"Extensive clinical evaluations of a highly attenuated live measles vaccine","volume":"199","author":"Swartz","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.04.059_bib0035","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jama.1968.03150030043009","article-title":"Development and evaluation of the Moraten measles virus vaccine","volume":"206","author":"Hillerman","year":"1968","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.04.059_bib0040","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1093\/clinids\/7.Supplement_1.S73","article-title":"Licensed vaccines","volume":"7","author":"Perkins","year":"1985","journal-title":"Rev Inf Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2011.04.059_bib0045","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2307\/3342210","article-title":"Universal childhood immunization by 1990","volume":"8","author":"Mandl","year":"1987","journal-title":"J Public Health Policy"},{"key":"10.1016\/j.vaccine.2011.04.059_bib0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00006454-199002000-00008","article-title":"Duration of live measles vaccine-induced immunity","volume":"9","author":"Markowitz","year":"1990","journal-title":"Pediatr Infect Dis"},{"key":"10.1016\/j.vaccine.2011.04.059_bib0055","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(52)91357-3","article-title":"Infectiousness of communicable diseases in the household","volume":"2","author":"Hope-Simpson","year":"1952","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.04.059_bib0060","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jama.1996.03530270064033","article-title":"Measles elimination in the Americas\u2014evolving strategies","volume":"275","author":"de Quadros","year":"1996","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2011.04.059_bib0065","article-title":"New horizons in the control of rubella and prevention of congenital rubella syndrome in the Americas","volume":"187","author":"Castillo-Solorzano","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.04.059_bib0070","series-title":"World Bank Development Report 1993: investing in health","year":"1993"},{"key":"10.1016\/j.vaccine.2011.04.059_bib0075","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1542\/peds.76.4.524","article-title":"Health impact of measles vaccination in the United States","volume":"76","author":"Block","year":"1985","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.04.059_bib0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-3-642-78621-1_2","article-title":"The epidemiology of measles: thirty years of vaccination","volume":"191","author":"Clements","year":"1995","journal-title":"Curr Top Microbiol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2011.04.059_bib0085","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1093\/infdis\/170.Supplement_1.S32","article-title":"Successes and failures in measles control","volume":"170","author":"Cutts","year":"1994","journal-title":"JID"},{"key":"10.1016\/j.vaccine.2011.04.059_bib0090","series-title":"Proceedings of the international conference on the application of vaccines against viral, rickettsial, and bacterial diseases of man, Scientific Publication No. 226","first-page":"207","article-title":"Measles vaccination in Africa","author":"Foege","year":"1971"},{"key":"10.1016\/j.vaccine.2011.04.059_bib0095","first-page":"171","article-title":"The elimination of measles from Cuba","volume":"4","author":"Galindo","year":"1998","journal-title":"RevPanam Salud Publica"},{"key":"10.1016\/j.vaccine.2011.04.059_bib0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev.pu.13.050192.001323","article-title":"Measles elimination in the Americas\u2014evolving strategies","volume":"13","author":"de Quadros","year":"1992","journal-title":"Ann Rev Public Health"},{"key":"10.1016\/j.vaccine.2011.04.059_bib0105","unstructured":"Pan American Health Organization. 44th Direction Council. Resolution CD44.R1 (http:\/\/www.paho.org\/English\/gov\/cd\/cd44-r1-e.pdf)."},{"key":"10.1016\/j.vaccine.2011.04.059_bib0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/S1020-49892004000300001","article-title":"Elimination of rubella and congenital rubella syndrome in the Americas: another opportunity to address inequities in health","volume":"15","author":"Andrus","year":"2004","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.vaccine.2011.04.059_bib0115","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3201\/eid1011.040428","article-title":"Rubella elimination and improving health care for women","volume":"10","author":"Castillo-Solorzano","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.059_bib0120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1590\/S1020-49892002000400017","article-title":"Accelerated rubella control and the prevention of congenital rubella syndrome","volume":"11","author":"Castillo-Sol\u00f3rzano","year":"2002","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.vaccine.2011.04.059_bib0125","series-title":"Final report XVI meeting of the technical advisory group on vaccine-preventable diseases","first-page":"1","author":"Pan American Health Organization","year":"2004"},{"issue":"43","key":"10.1016\/j.vaccine.2011.04.059_bib0130","first-page":"1176","article-title":"Progress toward elimination of rubella and congenital rubella syndrome\u2014the Americas, 2003\u20132008","volume":"57","author":"Castillo-Solorzano","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2011.04.059_bib0135","unstructured":"Icenogle J, Siqueira M, Abernathy E, et al. Virologic surveillance for wild-type rubella viruses in the Americas. JID Supplement; in press."},{"key":"10.1016\/j.vaccine.2011.04.059_bib0140","unstructured":"Andrus JK, Ropero AM, Ghisays G, Romero S, Jauregui B, Ruiz Matus C. Yellow fever and health diplomacy. Chapter in Health Diplomacy; in press."},{"key":"10.1016\/j.vaccine.2011.04.059_bib0145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/1471-2458-9-361","article-title":"Expansion of seasonal influenza vaccination in the Americas","volume":"9","author":"Ropero-Alvarez","year":"2009","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.059_bib0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050087","article-title":"Progress in vaccination against Hemphilus influenza Type b in the Americas","volume":"5","author":"Danovaro-Holiday","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2011.04.059_bib0155","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/009885880903500204","article-title":"New vaccines for developing countries: will it be feast or famine?","volume":"35","author":"Andrus","year":"2009","journal-title":"Am J Law Med"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.059_bib0160","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1590\/S1020-49892006000700012","article-title":"Regional programs for health: immunization as a model for strengthening inter-country cooperation and control of infectious diseases","volume":"20","author":"Tambini","year":"2006","journal-title":"Pan Am J Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11006049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11006049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T23:56:54Z","timestamp":1640044614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11006049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":32,"alternative-id":["S0264410X11006049"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.04.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}